Inspire Medical price target raised to $175 from $125 at RBC Capital

RBC Capital raised the firm’s price target on Inspire Medical (INSP) to $175 from $125 and keeps an Outperform rating on the shares as part of a broader research note previewing 2026 for Medical Supplies & Devices. The firm anticipates a year of positive momentum as sector fundamentals are solidly intact driven by the aging demographics, growing global healthcare access, and differentiated innovation, the analyst tells investors in a research note. For the company, RBC expects the pace of center additions and utilization per center aided by Inspire V to continue into 2026 and are accordingly modeling 10.5% y/y revenue and procedure volume growth in 2026.